Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Reactive capillary hemangiomas induced by camrelizumab (SHR-1210), an anti-PD-1 agent.

× No keyword cloud information.

6 in total

1. Camrelizumab (SHR-1210) leading to reactive capillary hemangioma in the gingiva: A case report.

Authors: Qing Yu; Wen-Xia Wang
Journal: World J Clin Cases Date: 2020-02-06 Impact factor: 1.337

Review 2. Polyreactivity and polyspecificity in therapeutic antibody development: risk factors for failure in preclinical and clinical development campaigns.

Authors: Orla Cunningham; Martin Scott; Zhaohui Sunny Zhou; William J J Finlay
Journal: MAbs Date: 2021 Jan-Dec Impact factor: 5.857

3. Adverse events of different PD-1 inhibitors in lung cancer patients: a real-world study.

Authors: Xiaowei Zheng; Gang Tao; Song Sun; Xiangni Jin; Yanning Chen; Yiwen Zhang; Jiao Sun; Ping Huang
Journal: Ann Transl Med Date: 2022-02

Review 4. Emerging agents and regimens for hepatocellular carcinoma.

Authors: Xiao-Dong Zhu; Hui-Chuan Sun
Journal: J Hematol Oncol Date: 2019-10-26 Impact factor: 17.388

Review 5. Oral reactive capillary hemangiomas induced by SHR-1210 in the treatment of non-small cell lung cancer: a case report and literature review.

Authors: Jinhan Zhou; Qinghua Mao; Yining Li; Zhiyong Li; Hong He; Qianming Chen; Chuanxia Liu
Journal: BMC Oral Health Date: 2021-11-02 Impact factor: 2.757

6. Efficacy and Safety of Camrelizumab Monotherapy and Combination Therapy for Cancers: A Systematic Review and Meta-Analysis.

Authors: Jiting Wang; Song Su; Jun Li; Yaling Li
Journal: Front Oncol Date: 2021-06-25 Impact factor: 6.244

6 in total